Table 1.
Demographics and clinical characteristics.
Subject | Age/Sex | PT duration | BMI | Side | Final diagnosis | Operation | Radiologic test | Objective tests | Subjective tests | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Empty sella | TSS | Pre-pseudo LFH at 250 Hz | Post-pseudo LFHL at 250 Hz | TSR/STA | Preop | Short | Long | ||||||||||
VAS Loud | VAS Annoy | VAS Loud | VAS Annoy | VAS Loud | VAS Annoy | ||||||||||||
1 | 55/F | 2 | 24.62 | R | SS-Deh | SS reshaping | NA | NA | (−) | (−) | NA | 5 | 5 | 0 | 0 | 0 | 0 |
2 | 33/F | 13 | 22.24 | L | SS-Deh | SS reshaping | NA | NA | (−) | (−) | NA | 10 | 10 | 8 | 8 | 8 | 8 |
3 | 36/F | 6 | 18.17 | L | SS-Div | SS resurfacing | NA | NA | (−) | (−) | NA | 6 | 7 | 3 | 3 | 3 | 3 |
4 | 62/M | 68 | 30.59 | R | SS-Div | SS resurfacing | Partial | (−) | (−) | (−) | NA | 9 | 9 | 10 | 6 | 4 | 4 |
5 | 41/F | 3 | 25.83 | R | SS-Div | SS resurfacing | (-) | (−) | (−) | (−) | NA | 3 | 2 | 0 | 0 | 0 | 0 |
6 | 41/M | 4 | 26.33 | L | SS-Deh Dural AVFa | SS reshaping | Partial | (−) | (−) | (−) | NA | 6 | 6 | 6 | 3 | 6 | 3 |
7 | 39/F | 4 | 23.88 | R | SS-Deh | SS reshaping | (−) | (−) | (−) | (−) | (+) | 1 | 2 | 1 | 2 | 0 | 0 |
8 | 42/F | 74 | 20.43 | R | SS-Div | SS resurfacing | Partial | (−) | (+), 55 dB HL | (+), 5 dB HL | (+) | 10 | 10 | 1 | 0 | 0 | 0 |
9 | 54/F | 36 | 22.92 | R | SS-Div | SS resurfacing | Partial | (−) | (−) | (−) | NA | 3 | 3 | 3 | 3 | 0 | 0 |
10 | 22/F | 13 | 25.16 | R | SS-Deh | SS reshaping | Partial | (+) | (+), 15 dB HL | (+), 5 dB HL | (+) | 6 | 7 | 9 | 2 | 0 | 0 |
11 | 39/F | 2 | 20.03 | R | SS-Deh | SS reshaping | (−) | (−) | (−) | (−) | NA | 8 | 7 | 8 | 8 | 4 | 3 |
12 | 25/F | 10 | 21.65 | R |
SS-Deh HJBDa |
SS reshaping JB resurfacing |
NA | NA | (+), 25 dB HL | (+), 10 dB HL | (+) | 7 | 7 | 8 | 8 | 6 | 5 |
13 | 35/F | 4 | 20.28 | R | SS-Deh | SS reshaping | Partial | (−) | (−) | (−) | (+) | 5 | 5 | 2 | 2 | 0 | 1 |
14 | 28/F | 13 | 25.49 | R | SS-Div | SS resurfacing | Partial | (+) | (−) | (−) | NA | 7 | 7 | 3 | 2 | 2 | 1 |
15 | 48/F | 74 | 25.86 | R | SS-Deh | SS reshaping | Partial | (−) | (+), 20 dB HL | (+), 5 dB HL | NA | 7 | 7 | 5 | 5 | 3 | 2 |
16 | 56/F | 8 | 20.73 | R | SS-Deh | SS reshaping | (−) | (−) | (−) | (−) | NA | 4 | 4 | 7 | 7 | 3 | 3 |
17 | 32/F | 5 | 22.9 | R | SS-Deh | SS reshaping | Empty | (+) | (+), 40 dB HL | (+), 15 dB HL | NA | 8 | 8 | 2 | 1 | 1 | 1 |
18 | 32/F | 135 | 33.97 | L | SS-Deh | SS reshaping | Partial | (−) | (−) | (−) | NA | 7 | 8 | 1 | 2 | 1 | 1 |
19 | 45/F | 13 | 24.65 | R | SS-Deh | SS reshaping | Partial | (+) | (+), 25 dB HL | (+), 15 dB HL | NA | 8 | 7 | 0 | 0 | 0 | 0 |
20 | 73/F | 12 | 22.12 | R | SS-Deh | SS reshaping | NA | NA | (−) | (−) | NA | 7 | 7 | 2 | 2 | 2 | 2 |
Abbreviation: PT, pulsatile tinnitus; BMI, body mass index; TSS, transverse sinus stenosis; LFHL, low-frequency hearing loss; TSR/STA, spectro-temporal analysis using short-time Fourier transform; VAS, visual analogue scale; Loud, loudness; Annoy, annoyance; M. male; F, female; R, right; L, left; SS, sigmoid sinus; AVF, arteriovenous fistula; HJBD, high jugular bulb dehiscence; NA, not available.
aNote that two subjects who manifest “slight improvement” had other vascular anomalies that may precipitate PT.